Improved Novel VaccIne CombinaTion InflUenza Study
Clinical trial NCT03300362 · TERMINATED
Trial details
- NCT number
- NCT03300362
- Sponsor
- Barinthus Biotherapeutics
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-13
- Primary completion
- 2018-10-31
- Enrollment
- 862
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.